New Enzyme Anhydrofructose-Reductase
The invention affects the novel bacterial enzyme 1,5-anhydro-D-fructose-reductase. In a regio- and stereoselective reaction 1,5-anhydro-D-fructose (AF) is quantitatively reduced to 1,5-anhydro-D-ma-nnitol. Generally AF occurs naturally in connection with the enzymatic degradation of storage poly-saccharides like starch or glycogen and the further eucaryotic metabolism results in the sugar polyol 1,5-anhydro-D-glucitol (so-called Third Gly-cogenolytic Pathway). The bacterial, NADPH-dependent enzyme exhibits a limited substrate spectrum and reduces other structure analogous 2-keto-aldoses. Due to the heterologous expression in E. coli the biocatalyst is available in sufficient amounts. The specific analysis of AF and selective synthesis of the manno-configurated reduction products are counted among the most important areas of application of the new AF-reductase.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/9386376
Contact
Dipl.-Kfm. Axel Koch MBA, Dr. Dirk Schwingel
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
